Todd A. Trapp

2021 - ABIOMED

In 2021, Todd A. Trapp earned a total compensation of $4.8M as Executive Vice President, Chief Financial Officer at ABIOMED, a 55% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$327,600
Option Awards$503,189
Salary$430,000
Stock Awards$3,496,819
Other$9,126
Total$4,766,734

Trapp received $3.5M in stock awards, accounting for 73% of the total pay in 2021.

Trapp also received $327.6K in non-equity incentive plan, $503.2K in option awards, $430K in salary and $9.1K in other compensation.

Rankings

In 2021, Todd A. Trapp's compensation ranked 2,761st out of 12,406 executives tracked by ExecPay. In other words, Trapp earned more than 77.7% of executives.

ClassificationRankingPercentile
All
2,761
out of 12,406
78th
Division
Manufacturing
1,092
out of 5,492
80th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
121
out of 798
85th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
75
out of 519
86th
Industry
Surgical and Medical Instruments and Apparatus
50
out of 324
85th
Source: SEC filing on June 28, 2022.

Trapp's colleagues

We found four more compensation records of executives who worked with Todd A. Trapp at ABIOMED in 2021.

2021

Michael Minogue

ABIOMED

Chief Executive Officer

2021

Marc Began

ABIOMED

General Counsel

2021

David Weber

ABIOMED

Chief Operating Officer

2021

Andrew Greenfield

ABIOMED

Executive Vice President and Chief Commercial Officer

News

You may also like